Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: J Thromb Thrombolysis. 2013 Feb;35(2):209–222. doi: 10.1007/s11239-012-0812-9

Fig 7.

Fig 7

Glycoprotein IIbIIIa expression in elective patients versus patients presenting with ACS. For all graphs shown, black bars depict levels of activated glycoprotein IIbIIIa expression before bivalirudin administration, while red bars depict post bivalirudin P-selectin expression levels. N = 52 for patients undergoing elective PCI, and N = 14 for ACS patients. Top panel Low and high dose thrombin stimulation. Middle panel low and high dose PAR1-AP stimulation. Bottom panel low and high dose PAR1-AP stimulation